Literature DB >> 11973119

Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics.

J-P Czerny1, P Briken, W Berner.   

Abstract

The aim of this study was to investigate which antihormonal treatment strategies are used in German forensic psychiatric institutions. Forensic clinics were asked about the number of treated patients. Four hundred seventy-four patients were committed for sex offences; 12% received either CPA (n = 29) or LHRH- agonists (n = 29). Differences in efficacy were small. Several side effects confirm the importance of a protocol for minimizing medical complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11973119     DOI: 10.1016/s0924-9338(02)00635-1

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  5 in total

1.  [Failure of a study in forensic psychiatric hospitals : Clinical trial to investigate the additive effect of triptorelin on the efficacy of psychotherapy].

Authors:  Peer Briken; Jürgen L Müller; Wolfgang Berner; Rolf-Hasso Bödeker; Jochen Vollmann; Christian Kasperk; Matthias Koller
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

Review 2.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 3.  The Biological Treatment of Paraphilic Disorders: an Updated Review.

Authors:  Brian J Holoyda; Denise C Kellaher
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

Review 4.  Pharmacologic treatment of sex offenders with paraphilic disorder.

Authors:  Frederico Duarte Garcia; Heloise Garcia Delavenne; Alessandra de Fátima Almeida Assumpção; Florence Thibaut
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

5.  The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning.

Authors:  Gian Lippi; Paul J van Staden
Journal:  S Afr J Psychiatr       Date:  2017-03-10       Impact factor: 1.550

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.